Ruth Sonntag Nussenzweig
#60,628
Most Influential Person Now
Brazilian physician, immunologist and parasitologist
Ruth Sonntag Nussenzweig's AcademicInfluence.com Rankings
Ruth Sonntag Nussenzweigbiology Degrees
Biology
#3540
World Rank
#5401
Historical Rank
Parasitology
#16
World Rank
#21
Historical Rank
Immunology
#363
World Rank
#377
Historical Rank
Ruth Sonntag Nussenzweigphilosophy Degrees
Philosophy
#6062
World Rank
#9029
Historical Rank
Logic
#3306
World Rank
#4439
Historical Rank
Download Badge
Biology Philosophy
Ruth Sonntag Nussenzweig's Degrees
- Doctorate Medicine University of São Paulo
Why Is Ruth Sonntag Nussenzweig Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ruth Sonntag Nussenzweig was an Austrian-Brazilian immunologist specializing in the development of malaria vaccines. In a career spanning over 60 years, she was primarily affiliated with New York University . She served as C.V. Starr Professor of Medical and Molecular Parasitology at Langone Medical Center, Research Professor at the NYU Department of Pathology, and finally Professor Emerita of Microbiology and Pathology at the NYU Department of Microbiology.
Ruth Sonntag Nussenzweig's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei (1967) (780)
- γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites (1987) (713)
- TRAP Is Necessary for Gliding Motility and Infectivity of Plasmodium Sporozoites (1997) (614)
- Migration of Plasmodium sporozoites through cells before infection. (2001) (563)
- Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria (1989) (503)
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites (1987) (497)
- Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. (1980) (465)
- Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection (1980) (420)
- Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. (1985) (346)
- Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. (1986) (328)
- Rationale for the development of an engineered sporozoite malaria vaccine. (1989) (311)
- Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes (1997) (300)
- Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes (1983) (297)
- Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax (1982) (271)
- Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. (1993) (269)
- Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses (2006) (267)
- Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies. (1984) (267)
- Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. (1999) (260)
- The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites (2006) (258)
- DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope. (1984) (226)
- CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. (1991) (224)
- Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope. (1985) (221)
- Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. (1967) (221)
- Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria (1990) (217)
- T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. (1993) (208)
- Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. (1994) (196)
- Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites (2004) (184)
- Circumsporozoite proteins of malaria parasites (1985) (182)
- Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity. (1969) (177)
- Structure of the plasmodium knowlesi gene coding for the circumsporozoite protein (1983) (174)
- Potential vectors of malaria and their different susceptibility to Plasmodium falciparum and Plasmodium vivax in northern Brazil identified by immunoassay. (1986) (167)
- Research toward malaria vaccines. (1986) (167)
- Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. (2000) (167)
- Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. (1987) (164)
- A Totally Synthetic Polyoxime Malaria Vaccine Containing Plasmodium falciparum B Cell and Universal T Cell Epitopes Elicits Immune Responses in Volunteers of Diverse HLA Types1 (2001) (155)
- Specificity of Protective Immunity produced by X-irradiated Plasmodium berghei Sporozoites (1969) (154)
- CD4+ cytolytic T cell clone confers protection against murine malaria (1990) (154)
- Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria. (1979) (145)
- Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi (1983) (140)
- Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. (1979) (138)
- Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen (2001) (136)
- The Plasmodium eukaryotic initiation factor-2α kinase IK2 controls the latency of sporozoites in the mosquito salivary glands (2010) (135)
- ELECTROPHORETIC SEPARATION AND PROPERTIES OF MOUSE ANTIHAPTEN ANTIBODIES INVOLVED IN PASSIVE CUTANEOUS ANAPHYLAXIS AND PASSIVE HEMOLYSIS (1964) (133)
- The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules (1992) (124)
- Safety and Enhanced Immunogenicity of a Hepatitis B Core Particle Plasmodium falciparum Malaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I Trial (2005) (120)
- Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. (1994) (120)
- Synthetic peptide vaccine confers protection against murine malaria (1987) (119)
- Biosynthesis of Pb44, the protective antigen of sporozoites of Plasmodium berghei (1981) (117)
- Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis. (1979) (111)
- Monoclonal antibodies to circumsporozoite proteins identify the species of malaria parasite in infected mosquitoes (1982) (106)
- Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. (1996) (103)
- The circumsporozoite gene of the plasmodium cynomolgi complex (1987) (102)
- Increased nonspecific resstance to malaria produced by administration of killed Corynebacterium parvum. (1967) (102)
- Antibodies to the protective antigen of Plasmodium berghei sporozoites prevent entry into cultured cells. (1982) (96)
- Development of antimalaria immunity in mice lacking IFN-gamma receptor. (1995) (95)
- Immune phagocytosis in murine malaria (1979) (93)
- Recombinant Sindbis Viruses Expressing a Cytotoxic T-Lymphocyte Epitope of a Malaria Parasite or of Influenza Virus Elicit Protection against the Corresponding Pathogen in Mice (1998) (93)
- Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus. (1984) (92)
- Monoclonal antibodies identify the protective antigens of sporozoites of Plasmodium knowlesi. (1982) (92)
- Further studies on the Plasmodium berghei-Anopheles stephensi--rodent system of mammalian malaria. (1968) (92)
- Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice. (1998) (92)
- Interferon Inducers Protect Mice against Plasmodium berghei Malaria (1968) (91)
- Identification of malaria-infected mosquitoes by a two-site enzyme-linked immunosorbent assay. (1984) (90)
- Prevalence and levels of antibodies to the circumsporozoite protein of Plasmodium falciparum in an endemic area and their relationship to resistance against malaria infection. (1988) (87)
- A Modified Hepatitis B Virus Core Particle Containing Multiple Epitopes of the Plasmodium falciparum Circumsporozoite Protein Provides a Highly Immunogenic Malaria Vaccine in Preclinical Analyses in Rodent and Primate Hosts (2002) (87)
- Levels of circumsporozoite protein in the Plasmodium oocyst determine sporozoite morphology (2002) (85)
- The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria. (1993) (81)
- First field trial of an immunoradiometric assay for the detection of malaria sporozoites in mosquitoes. (1984) (79)
- Anophelines in the state of Acre, Brazil, infected with Plasmodium falciparum, P. vivax, the variant P. vivax VK247 and P. malariae. (1993) (79)
- Sporozoites of mammalian malaria: attachment to, interiorization and fate within macrophages. (1980) (78)
- A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8(+) T cells. (2001) (77)
- Development of sporozoite vaccines. (1984) (76)
- Gene targeting in the rodent malaria parasite Plasmodium yoelii. (2001) (72)
- Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein (1991) (72)
- Malaria vaccines: multiple targets. (1994) (72)
- Antibody-induced ultrastructural changes of malarial sporozoites. (1976) (71)
- Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein. (1998) (71)
- Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials. (1999) (69)
- Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites. (1985) (67)
- Immunization against Sporozoites (1980) (64)
- Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. II. Effects of radiation on sporozoites. (1968) (62)
- Exogenous Interferon protects Mice against Plasmodium berghei Malaria (1970) (60)
- Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei (1988) (58)
- The protective antigen of malarial sporozoites (Plasmodium berghei) is a differentiation antigen. (1981) (58)
- Plasmodium berghei: suppression of antibody response to sporozoite stage by acute blood stage infection. (1979) (58)
- Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice. (1999) (57)
- Comparative studies on the immunogenicity of infective and attenuated sporozoites of Plasmodium berghei. (1982) (57)
- Yellow fever 17D as a vaccine vector for microbial CTL epitopes (2005) (57)
- Sero-epidemiological studies of malaria in Indian tribes and monkeys of the Amazon Basin of Brazil. (1989) (56)
- Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus. (2002) (54)
- Structural similarities among the protective antigens of sporozoites from different species of malaria parasites. (1983) (53)
- Sporozoite-induced immunity in mammalian malaria. A review. (1972) (53)
- Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum. (1993) (52)
- Circumsporozoite gene of plasmodium cynomolgi (Gombak):cDNA cloning and expression of the repetitive circumsporozoite epitope. (1984) (51)
- Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax. (1989) (50)
- The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases. (1995) (49)
- Inhibition of idiotype--anti-idiotype interaction for detection of a parasite antigen: a new immunoassay. (1982) (49)
- Development of novel influenza virus vaccines and vectors. (1997) (48)
- Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers. (1992) (48)
- Development of a sporozoite malaria vaccine. (1986) (48)
- Neutralization of the infectivity of sporozoites of Plasmodium knowlesi by antibodies to a synthetic peptide (1984) (47)
- Immuno-electron microscopic observations on Plasmodium knowlesi sporozoites: localization of protective antigen and its precursors. (1984) (47)
- Plasmodium berghei: accelerated clearance of sporozoites from blood as part of immune-mechanism in mice. (1972) (46)
- Induction of Protective Immunity against Malaria by Priming-Boosting Immunization with Recombinant Cold-Adapted Influenza and Modified Vaccinia Ankara Viruses Expressing a CD8+-T-Cell Epitope Derived from the Circumsporozoite Protein of Plasmodium yoelii (2003) (45)
- Susceptibility of Anopheles culicifacies species A and B to Plasmodium vivax and Plasmodium falciparum as determined by immunoradiometric assay. (1988) (45)
- Circumsporozoite gene of a Plasmodium falciparum strain from Thailand. (1987) (45)
- Efficient induction of protective anti-malaria immunity by recombinant adenovirus. (1998) (45)
- Anti-malarial Effect of Interferon Inducers at Different Stages of Development of Plasmodium berghei in the Mouse (1968) (44)
- Role of Anopheles culicifacies sibling species in malaria transmission in Madhya Pradesh state, India. (1992) (44)
- Circumsporozoite proteins of malaria parasites. (1985) (43)
- Plasmodium berghei sporozoites are mitogenic for murine T cells, induce interferon, and activate natural killer cells. (1984) (43)
- Antisporozoite vaccine for malaria: experimental basis and current status. (1989) (43)
- Widespread reactivity of human sera with a variant repeat of the circumsporozoite protein of Plasmodium vivax. (1990) (42)
- Plasmodium berghei: relationship between protective immunity and anti-sporozoite (CSP) antibody in mice. (1973) (41)
- Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application. (1994) (40)
- Depletion of T and B lymphocytes during malarial infections. (1974) (40)
- Erythrocyte membrane-associated immunoglobulins during malaria infection of mice. (1977) (40)
- Protective effect of interferon inducers on Plasmodium berghei malaria. (1969) (39)
- Progress toward malaria preerythrocytic vaccines. (1991) (39)
- Plasmodium berghei: T cell dependence of sporozoite-induced immunity in rodents. (1977) (39)
- Stage-specific antigens on the surface membrane of sporozoites of malaria parasites (1978) (39)
- Isolation and characterization of protective cytolytic T cells in a rodent malaria model system. (1990) (38)
- Plasmodium falciparum: restricted polymorphism of T cell epitopes of the circumsporozoite protein in Brazil. (1990) (37)
- Ultrastructure of in vitro cultured exoerythrocytic stage of Plasmodium berghei in a hepatoma cell line. (1984) (36)
- Monoclonal antibodies produced against sporozoites of the human parasite Plasmodium malariae abolish infectivity of sporozoites of the simian parasite Plasmodium brasilianum (1985) (36)
- Phenotypic and functional properties of murine γδ T cell clones derived from malaria immunized, αβ T cell-deficient mice (1996) (35)
- Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein. (1996) (34)
- A malaria vaccine based on a sporozoite antigen. (1997) (33)
- Antibodies to Plasmodium circumsporozoite protein (CSP) inhibit sporozoite's cell traversal activity. (2012) (33)
- Characterization of sporozoite surface antigens by indirect immunofluorescence: detection of stage- and species-specific antimalarial antibodies. (1979) (32)
- A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates (2009) (32)
- Trichinella spiralis: anaphylactic antibody formation and susceptibility in strains of inbred mice. (1976) (32)
- Detection and anatomical localization of Plasmodium falciparum circumsporozoite protein and sporozoites in the afrotropical malaria vector Anopheles gambiae s.l. (1987) (31)
- Pfs2400 can mediate antibody-dependent malaria transmission inhibition and may be the Plasmodium falciparum 11.1 gene product (1993) (31)
- The antibody response to sporozoites of simian and human malaria parasites: its stage and species specificity and strain cross-reactivity. (1974) (31)
- Monoclonal antibody identifies circumsporozoite protein of Plasmodium malariae and detects a common epitope on Plasmodium brasilianum sporozoites (1984) (30)
- Immunological studies in rodent malaria. I: Protective immunity induced in mice by mild strains of Plasmodium berghei yoelii against a virulent and fatal line of this plasmodium. (1975) (30)
- Plasmodium chabaudi and Plasmodium vinckei: phagocytic activity of mouse reticuloendothelial system. (1969) (30)
- Susceptibility of genetically standardized (JAX) mouse strains to sporozoite- and blood-induced Plasmodium berghei infections. (1966) (30)
- Studies on sporozoite-induced infections of rodent malaria. 3. The course of sporozoite-induced Plasmodium berghei in different hosts. (1966) (29)
- Parasitic disease as a cause of immunosuppression. (1982) (29)
- Human immune system mice immunized with Plasmodium falciparum circumsporozoite protein induce protective human humoral immunity against malaria. (2015) (29)
- 6 – Immunological Responses (1978) (29)
- Subtle Mutagenesis by Ends-in Recombination in Malaria Parasites (1999) (29)
- A circumsporozoite-like protein is present in micronemes of mature blood stages of malaria parasites. (1989) (27)
- Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice (2016) (27)
- Antigenic diversity of the circumsporozoite proteins in the Plasmodium cynomolgi complex. (1985) (27)
- Circumsporozoite protein of Plasmodium gallinaceum characterized by monoclonal antibodies (1988) (26)
- Immunofluorescent staining of exoerythrocytic schizonts of Plasmodium berghei in fixed liver tissue with stage-specific immune serum. (1978) (26)
- Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii. (2010) (26)
- Progress toward a Malaria Vaccine: Efficient Induction of Protective Anti-Malaria Immunity (2001) (25)
- Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites. (1990) (24)
- Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge (2018) (24)
- Active immunization and passive transfer of resistance against sporozoite-induced malaria in infant mice (1981) (23)
- Conserved group-specific epitopes of the circumsporozoite proteins revealed by antibodies to synthetic peptides. (1985) (23)
- T cell epitopes of the circumsporozoite protein of Plasmodium vivax. Recognition by lymphocytes of a sporozoite-immunized chimpanzee. (1991) (23)
- Prevalence and level of antibodies to the circumsporozoite proteins of human malaria parasites, including a variant of Plasmodium vivax, in the population of two epidemiologically distinct areas in the state of Acre, Brazil. (1992) (23)
- Freeze-fracture study of malaria sporozoites: antibody-induced changes of the pellicular membrane. (1979) (23)
- Resistance of Plasmodium chabaudi-Infected White Mice to a Fulminating and Fatal Strain of Plasmodium vinckei (1966) (23)
- Immunoradiometric assay to measure the in vitro penetration of sporozoites of malaria parasites into hepatoma cells. (1985) (23)
- Plasmodium berghei: the spleen in sporozoite-induced immunity to mouse malaria. (1976) (22)
- Immunogenicity of a Prime-Boost Vaccine Containing the Circumsporozoite Proteins of Plasmodium vivax in Rodents (2013) (22)
- Evolutionary profile of the circumsporozoite gene of the Plasmodium cynomolgi complex. (1986) (22)
- Antigenic analysis of the repeat domain of the circumsporozoite protein of Plasmodium vivax. (1987) (22)
- Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites. (2011) (22)
- Ultrastructural localization of the 150/130 Kd antigens in sexual and asexual blood stages of Plasmodium falciparum-infected human erythrocytes. (1987) (21)
- Immunogenicity and infectivity of sporozoites of mammalian malaria isolated by density-gradient centrifugation. (1973) (20)
- Immunization against rodent malaria with cryopreserved irradiated sporozoites of Plasmodium berghei. (1980) (20)
- Delayed-type hypersensitivity in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites. (2002) (19)
- Further studies on the immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax. (1990) (19)
- Further studies on the antigenic diversity of the circumsporozoite proteins of the Plasmodium cynomolgi complex. (1986) (19)
- Structure of an immunodominant epitope of the circumsporozoite surface protein of Plasmodium knowlesi. (1984) (19)
- Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite (2017) (19)
- Congenital transfer of antibodies against malarial sporozoites detected in Gambian infants. (1981) (18)
- T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites. (1992) (18)
- Prairie Dogs Avoid Extreme Inbreeding (18)
- Monoclonal Antibodies to Trypanosoma cruzi Inhibit Motility and Nucleic Acid Synthesis of Culture Forms (1983) (18)
- Complement-mediated defect in clearance and sequestration of sensitized, autologous erythrocytes in rodent malaria. (1981) (17)
- TLR5-dependent immunogenicity of a recombinant fusion protein containing an immunodominant epitope of malarial circumsporozoite protein and the FliC flagellin of Salmonella Typhimurium. (2011) (17)
- Studies on the protective effect of Plasmodium chabaudi infection in mice upon a subsequent infection with another rodent malaria species, plasmodium vinckei. (1966) (17)
- Association of microneme antigens of Plasmodium brasilianum merozoites with knobs and other parasite-induced structures in host erythrocytes (1989) (17)
- Sporozoites of rodent and simian malaria, purified by anion exchangers, retain their immunogenicity and infectivity. (1978) (16)
- Identification of circumsporozoite proteins in individual malaria-infected mosquitoes by western blot analysis. (1984) (16)
- Membrane-associated antigens of blood stages of Plasmodium, brasilianum, a quartan malaria parasite (1988) (15)
- Fine structure of Haemobartonella sp. in the squirrel monkey. (1972) (15)
- Estimate of Plasmodium falciparum sporozoite content of Anopheles stephensi used to challenge human volunteers. (1989) (14)
- [Antibodies against sporozoites of human and simian malaria produced in rats]. (1973) (14)
- Immunoprophylaxis of malaria: sporozoite-induced immunity. (1977) (14)
- Use of radiation-attenuated sporozoites in the immunoprophylaxis of malaria. (1980) (14)
- Complement alterations in rodent malaria. (1976) (13)
- Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers. (1990) (13)
- Specificity of the circum-sporozoite precipitation antigen(s) of human and simian malarias. (1976) (12)
- Inhibitory activity against Plasmodium vivax sporozoites induced by plasma from Saimiri monkeys immunized with circumsporozoite recombinant proteins or irradiated sporozoites. (1991) (11)
- Development of a sporozoite vaccine. (1985) (11)
- Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus. (2000) (10)
- Enhancement of a simian malarial infection (Plasmodium cynomolgi) in mosquitoes fed on rhesus (Macaca mulatta) previously infected with an unrelated malaria (Plasmodium knowlesi). (1979) (9)
- Experimental basis for the development of a synthetic vaccine against Plasmodium falciparum malaria sporozoites. (1986) (8)
- Variation of T cell epitopes of the Plasmodium falciparum CS protein: its occurrence, extent and relevance. (1990) (8)
- Monoclonal anti-gametocyte antibodies identify an antigen present in all blood stages of Plasmodium falciparum. (1986) (8)
- Induction of sporozoite‐specific memory cells in mice immunized with a recombinant Plasmodium vivax circumsporozoite protein (1987) (7)
- Immunity to Plasmodium sporozoites: recent advances and applications to field research. (1986) (7)
- Malaria vaccine against sporozoites? (1985) (7)
- Serological investigation of human plasmodium vivax -like malaria in several localities in the state of sao paulo , brazil (1995) (6)
- Characterization of cross-reactive blood-stage antigens of the Plasmodium cynomolgi complex using anti-Plasmodium vivax monoclonal antibodies. (1988) (6)
- Progress in malaria vaccine development: characterization of protective antigens. (1982) (6)
- Laboratory assessment of a species-specific radioimmunoassay for the detection of malaria sporozoites in mosquitoes (Diptera: Culicidae). (1985) (6)
- Immune Phagocytosis in Murine Malaria* Materials and Methods Reagents. Phosphate-buffered Saline (pbs) 1 without Ca ++ and Mg ++, Dulbecco's Modified (1979) (5)
- Plasmodium falciparum: epidemiological studies on the circumsporozoite gene. (1987) (5)
- Rationale for Malaria Vaccine Development (2004) (5)
- Observations on the Diagnosis of Chronic Toxoplasma Infection in Mice. (1959) (4)
- Immunoprophylaxis of malaria: characterization of a protective surface antigen. (1982) (4)
- Species-specific epitope is identical in phenotypically different circumsporozoite proteins of human malaria (1984) (4)
- Phenotypic and functional properties of murine gamma delta T cell clones derived from malaria immunized, alpha beta T cell-deficient mice. (1996) (4)
- Progress toward a malaria vaccine. (1990) (3)
- Presence of a circumsporozoite-like protein in micronemes of blood-stage merozoites of malaria parasites. (1990) (3)
- Recombinant proteins and synthetic peptides as malaria vaccine candidates. (1990) (3)
- Malaria vaccines: experience with sporozoite vaccines against falciparum malaria. (1988) (3)
- Evaluation of a method for in vitro ookinete development of the rodent malarial parasite, Plasmodium berghei. (1975) (3)
- y6 T cells contribute to immunity against the liver stages of malaria in c43 T-cell-deficient mice (2005) (2)
- The epitope specificity of anti-P. falciparum sporozoite antibodies present in human sera from endemic areas (1985) (2)
- Recent advances in the development of a sporozoite vaccine for malaria. (1984) (2)
- Some characteristics of the immune response to sporozoites of simian and human malaria. (1974) (2)
- Detection of anti-Plasmodium falciparum antibodies directed against a repetitive peptide of the gametocyte antigen Pfs2400 in malaria patients in Brazil. (1995) (2)
- Tropical diseases: Progress on Theileria vaccine (1985) (2)
- Erratum: Immunogenicity of Ty-VLP bearing a CD8+ T cell epitope of the CS protein of P. yoelii: Enhanced memory response by boosting with recombinant vaccinia virus (Vaccine (2000) 18 (1863-1869) PII: S0264410X99003448) (2000) (1)
- Sporozoite malaria vaccines. (1988) (1)
- Circumsporozoite proteins. A family of protective malarial antigens (1982) (1)
- Breakthroughs towards a malaria vaccine. (2011) (1)
- MINIREVIEW A Striking Property of Recombinant Poxviruses: Efficient Inducers of in Vivo Expansion of Primed CD8 1 T Cells (2001) (1)
- [Various characteristics of the immune response to sporozoites of simian and human malaria]. (1974) (1)
- Human Malaria: standardization of the Enzymeimmunoassay (ELISA) to detect sporozoites in mosquitoes (1986) (1)
- Prevalence of plasmodium spp in anopheles spp in goldmining areas of amapa state, brazil, detected by immunoenzymatic assay (1993) (1)
- Observations on the Diagnosis and Epidemiology of Canine Visceral Leishmaniasis in the Fortaleza Area, Geara, Brazil. Serological Survey by Means of the Complement-Fixation Reaction with an Antigen extracted from Tubercle Bacilli. (1957) (1)
- [Toxoplasmosis; serological examination by the dye test in blood donors]. (1958) (0)
- Rodent and Primate Hosts Malaria Vaccine in Preclinical Analyses in Protein Provides a Highly Immunogenic Circumsporozoite Plasmodium falciparum Containing Multiple Epitopes of the A Modified Hepatitis B Virus Core Particle (2002) (0)
- Complement-Fixation Test for Canine Visceral Leishmaniasis with Myco. tuberculosis Antigen. (1957) (0)
- Malaria vaccine trials. (1988) (0)
- Development of a Sporozoite Vaccine against Malaria (1986) (0)
- HLA Types Immune Responses in Volunteers of Diverse B Cell and Universal T Cell Epitopes Elicits Plasmodium falciparum Vaccine Containing A Totally Synthetic Polyoxime Malaria (2000) (0)
- Immunogenicity of MAPs containing B and T cell epitopes of a malarial antigen, the circumsporozoite protein (1991) (0)
- [Effects of physical and chemical agents of Trypanosoma cruzi in vitro]. (1954) (0)
- Monoclonal antibodies recognize a 150 KDa antigen in sexual and asexual stages of Plasmodium falciparum (1985) (0)
- Malaria endemic sera identify B cell epitopes within non repeat regions of the circumsporozoite protein of Plasmodium falciparum (1991) (0)
- Antibodies against sporozoites of human and simian malaria produced in rats. (1973) (0)
- HOMOLOGOUS AND HETEROLOGOUS PRIME BOOST VACCINATIONS WITH DISTINCT VARIANTS OF PLASMODIUM VIVAX CIRCUMSPOROZOITE PROTEIN (CSP) PROTECTS MICE AGAINST TRANSGENIC PB/PV SPOROZOITE CHALLENGE (2017) (0)
- 1948 IMMUNODOMINANT REGION OF CIRCUMSPOROZOITE PROTEINS purified from ascites fluids by ammonium sulfate precipitation followed by chromatography on Sephadex G 200 (2003) (0)
- Sporozoite Ligand and Hepatocyte Receptors of Malaria Parasites(Abstracts from the Malaria Workshop) (1997) (0)
- [Studies on the transmission of Toxoplasma gondii. I. Experiences with triatomes]. (1958) (0)
- CS antigen localization in malaria vectors: hypothetical refractoriness to transmission observed in the field. (1986) (0)
- Protective immune effector mechanisms against malaria (1998) (0)
- Antibody and cellular responses to maps of cs protein and hla haplotype of individuals living in a malaria endemic area , in brazil (1996) (0)
- Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge (2018) (0)
- Circumsporozoite Proteins of Human Malaria Para 11 Patent Number : 45 ) Date of Patent : 4 , 466 , 917 Aug . 21 , 1984 sites Plasmodium Falciparum and Plasmodium Vivax (2017) (0)
- Phenotypic and functional properties of murine yS T cell clones derived from malaria immunized, a(3 T cell-deficient mice (2004) (0)
- Anticorpos dirigidos contra um peptideo repetitivo do antigeno pfs 2400 de gametocitos em pacientes com parasitemia patente por plasmodium falciparum (1995) (0)
- Progress on Theileria vaccine. (1985) (0)
- Chagas's Disease and Blood Banks. (1955) (0)
- [On the metabolism of 3,5-diiodo-L-tyrosine in the rabbit]. (1960) (0)
- Immunology and chemotherapy of Plasmodium. (1990) (0)
- [On the predominance of glucuronic acid conjugates in rabbit urine following injection of 3, 5, 3'-triiodothyroaetic acid and 3, 5, 3'-triiodo-L-thyronine]. (1960) (0)
- Patents and literature (1985) (0)
- Circumsporozoite gene of Plasmoidium (0)
- Seasonal variation of anti-plasmodium falciparum antibodies directed against gametocyte antigen pfs 2400 in three localities in amapa , brazil (1995) (0)
- Proceedings of the round-table on parasite antigens and molecular biology (1986) (0)
- Action of Physical and Chemical Agents upon Trypanosoma cruzi in vitro. (1954) (0)
- Studies on the Transmission of Toxoplasma gondii. I. Experiments with Triatomid bugs. (1958) (0)
This paper list is powered by the following services:
Other Resources About Ruth Sonntag Nussenzweig
What Schools Are Affiliated With Ruth Sonntag Nussenzweig?
Ruth Sonntag Nussenzweig is affiliated with the following schools:
